Global prescription dermatology therapeutics market expected to generate around USD 53.9 billion by 2024, at a CAGR of around 9.9% between 2018 and 2024. Skin is vulnerable to a wide variety of toxins and microbes as it is the largest and most exposed organ. Prolonged exposure of skin to toxins results in various kinds of skin disorders.
